LEMASTERS CHRISTOPHER C. 4
4 · Mirati Therapeutics, Inc. · Filed Jan 22, 2018
Insider Transaction Report
Form 4
LEMASTERS CHRISTOPHER C.
EVP, Chief Business Officer
Transactions
- Award
Option Grant (Right to Buy)
2018-01-18+65,000→ 65,000 totalExercise: $27.00Exp: 2028-01-17→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.